ClinicalTrials.gg
RecruitingNCT06171477Updated May 3, 2024

Regional Distribution of Ventilation at Different Respiratory Rates

An interventional study of Ventilation 20-40-60 and Ventilation 60-40-20 in Mechanical Ventilation, Atelectasis and Distribution of Ventilation, sponsored by Region Örebro County. Recruiting at 1 site in Sweden. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-03.

Sponsored by Region Örebro County · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Pulmonary Atelectasis with a site in Sweden — 5 open to participants now, 5 under way, none of them phase 3. Pulmonary Atelectasis · Sweden.

Planned enrollment
9th of 10
15 · median 30
Started
2024
with 1 other
No phase
10 of 16
3 open now
Registered
14th of 16
by date
Lead sponsor
1 of 16
Region Örebro County

Among the 16 studies in Pulmonary Atelectasis with a site in Sweden, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2024, is one of 10 with no phase, and was the 14th registered.

Pulmonary Atelectasis

378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.

Browse Pulmonary Atelectasis studies →

Open to participants now

5 of the 16 studies in Pulmonary Atelectasis with a site in Sweden are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Pulmonary Atelectasis with a site in Sweden, or all of them as a file.
02

Study summary

This study will investigate the distribution of gas during mechanical ventilation in patients undergoing robot assisted laparoscopic prostatectomy. The gas distribution of ventilation are monitored and data extracted using electric impedance tomography in different respiratory rates.

Read the detailed description

Mechanical ventilation during anaesthesia and intensive care often results in an uneven gas distribution of ventilation. Patients anaesthetized for laparoscopic surgery and patients positioned i a Trendelenburg position is particularly at risk.

A less harmful mode of ventilation could possible lead to a more optimal ventilation with avoidance of ventilator induced lung injuries. The project will investigate if volume controlled ventilation with a higher respiratory frequency can be used in this purpose.

The researchers intend to investigate patients, without previously known lung disease, undergoing robot-assisted laparoscopic prostatectomy. After the patients have given informed consent, they will be included in the project. The distribution of ventilation will be monitored with electric impedance tomography (EIT). Once the patients have been anaesthetized, positioned with the head down and the surgical procedure have been started with insufflation of carbon dioxide we will start our test.

The investigators will perform three episodes of standardized ventilation with the respiratory rate (RR) of 20, 40 and 60. With a higher RR the tidal volume will be reduced tom maintain a constant inhaled minute volume. Data will be collected from the EIT-equipment, the anaesthesia machine and the monitoring system.

03

Conditions studied

  • Mechanical Ventilation
  • Atelectasis
  • Distribution of Ventilation

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients planned for robot-assisted laparoscopic prostatectomy
  • > 18 years
  • Consent to take part in the study

Exclusion criteria

Exclusion Criteria:

  • Impaired cognitive function
  • Previously known lung disease
  • Insufficient skills in Swedish language to understand information about the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    20-40-60

    Device: Ventilation 20-40-60

  • Experimental
    60-40-20

    Device: Ventilation 60-40-20

  • Experimental
    40-60-20

    Device: Ventilation 40-60-20

Interventions

  • DeviceVentilation 20-40-60

    The respiratory rate during mechanical ventilation will be altered from 20 to 40 and finally to 60 breaths per minute.

  • DeviceVentilation 60-40-20

    The respiratory rate during mechanical ventilation will be altered from 60 to 40 and finally to 20 breaths per minute.

  • DeviceVentilation 40-60-20

    The respiratory rate during mechanical ventilation will be altered from 40 to 60 and finally to 20 breaths per minute.

06

What researchers measure

Primary outcomes

  1. Distribution of ventilation

    Gas distribution of ventilation between different regions of interest monitored with electrical impedance tomography.

    Time frame: During the prostatectomy procedure

Secondary outcomes

  1. Distribution of ventilation

    Gas distribution of ventilation measured as center of ventilation monitored with electrical impedance tomography.

    Time frame: During the prostatectomy procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Jun 2024, 1 month after the start.

Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 1 month is below that.

Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 6, 2023
First posted
Dec 14, 2023
StartActual
May 2, 2024
Primary completionEst.
Jun 30, 2024
CompletionEst.
Dec 31, 2024
Last update
May 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06171477
Responsible party
Sponsor
First posted
Dec 14, 2023
Start date
May 2, 2024
Primary completion
Jun 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
May 3, 2024

Study contacts

Erik Wikström, MD
Contact
erik.wikstrom@regionorebrolan.se
+46196025907
Pether Jildenstål, PhD
Contact
pether.jildenstal@regionorebrolan.se
Pether Jildenstål, PhD
study director · Örebro University, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion